Clinical Application of (18)F-FDG PET in Multiple Myeloma.
- Author:
Su Jin LEE
1
;
Joon Young CHOI
Author Information
1. Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. jynm.choi@samsung.com
- Publication Type:Review
- Keywords:
Multiple myeloma;
(18)F-FDG;
PET;
clinical application
- MeSH:
Diagnosis, Differential;
Monoclonal Gammopathy of Undetermined Significance;
Multiple Myeloma;
Plasmacytoma
- From:Nuclear Medicine and Molecular Imaging
2009;43(6):509-512
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
This review focuses on the clinical use of (18)F-FDG PET to evaluate multiple myeloma. (18)F-FDG PET is useful for diagnosis, staging of multiple myeloma and differential diagnosis of myeloma related disease such as monoclonal gammopathy of undetermined significance or plasmacytoma. For therapy response, (18)F-FDG PET may be effective after chemotherapy for multiple myeloma and radiotherapy for plasmacytoma.
